Shefali Agarwal, MD
Before joining Valerio Therapeutics, Dr. Shefali Agarwal was Chief Medical Officer at Epizyme, Inc., a clinical-stage company developing novel epigenetic […]
Before joining Valerio Therapeutics, Dr. Shefali Agarwal was Chief Medical Officer at Epizyme, Inc., a clinical-stage company developing novel epigenetic […]
Khalil Barrage is a Managing Director at Invus, based in New York. He joined Invus in 2003 and established its […]
Robert L. Coleman, MD, is the Chief Scientific Officer of US Oncology Research, one of the U.S. largest networks dedicated […]
Bryan Giraudo is both the Chief Operating Officer & Chief Financial Officer of Gossamer Bio, a U.S. listed biopharmaceutical company […]
Jacques Mallet, MD, served as SVP – Head of Portfolio Analytics/Corporate Strategy and Member of the Executive Leadership Team of […]
Julien Miara is a Principal at Invus. He joined in 2010 as an analyst in the Public Equity group, covering […]
Dr. Jiang has more than 25 years of extensive pharma and biotech experience. Huiping began her pharmaceutical career at AstraZeneca […]
He began his career as Deputy Chief Financial Officer at Total in Cameroon in 1990 and then as Financial Auditor […]
Since 2005, Olivier de Beaumont was with Stallergenes Greer as Senior Vice President, Head of Global Clinical Development, Pharmacovigilance and […]
Joseph Donahue is an end-to-end drug development professional with over 15 years of biotech and CRO experience. Joe has extensive product […]
Laura Sierra has over 10 years of experience in translational and clinical research, holding increasingly responsible roles in clinical development […]
Ashish Gulati has more than 20 years of experience in the healthcare field: after a career in research at the […]
Nicolas Trebouta is a Doctor of Medicine. Co-founder of Chevrillon and Associates in 2000, Nicolas Trebouta has lead several buyouts […]
Robin Sutherland brings over two decades of executive leadership experience, with 12 years of HR leadership within the biotech industry. […]
Donna Cabral-Lilly has over 20 years of experience in the pharma and biotech space, with a proven track record for […]
Joyce Carey brings 30 years of finance and accounting experience to Valerio Therapeutics. Her experience ranges from small biotechs to […]
Prior to joining Valerio Therapeutics, Wael Jdey was a junior scientist at Gustave Roussy Cancer Center (Villejuif, France) and then […]
Pam, a recognized industry leader, joins Valerio Therapeutics with over 20 years of experience in safety profile characterization and risk […]